AU2020210160B2 — Compositions, methods & systems for respiratory delivery of two or more active agents
Assigned to Pearl Therapeutics Inc · Expires 2022-06-30 · 4y expired
What this patent protects
of the Disclosure Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending 5 particles, in wh…
USPTO Abstract
of the Disclosure Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending 5 particles, in which the active agent particles and suspending particles form a co suspension within the suspension medium.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.